About TiGenix
TiGenix is a company based in Leuven (Belgium) founded in 2000 was acquired by Takeda in January 2018.. TiGenix has raised $19 million across 15 funding rounds from investors including Takeda Pharmaceuticals, RA Capital and Kreos Capital. TiGenix has completed 2 acquisitions, including Cellerix and Orthomimetics. TiGenix operates in a competitive market with competitors including Tenaya Therapeutics, Cellino, Arrakis Therapeutics, MyoKardia and Eiger BioPharmaceuticals, among others.
- Headquarter Leuven, Belgium
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19 M (USD)
in 15 rounds
-
Latest Funding Round
$25.9 K (USD), Post-IPO
Nov 16, 2017
-
Investors
Takeda Pharmaceuticals
& 15 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cellerix
& 1 more
-
Acquired by
Takeda
(Jan 05, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of TiGenix
TiGenix has successfully raised a total of $19M across 15 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25.9 thousand completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 15
- Last Round Post-IPO — $25,902
-
First Round
First Round
(05 Jan 2006)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2017 | Amount | Post-IPO - TiGenix | Valuation |
investors |
|
| Mar, 2016 | Amount | Post-IPO - TiGenix | Valuation |
investors |
|
| Nov, 2015 | Amount | Post-IPO - TiGenix | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TiGenix
TiGenix has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Takeda Pharmaceuticals, RA Capital and Kreos Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Brightlands Venture Partners is focused on venture capital investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TiGenix
TiGenix has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cellerix and Orthomimetics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Resorbable implant for minimally invasive repair of small osteochondral defects
|
2005 | ||||
|
Stem Cell Therapy for the treatment of gastroenterology, dermatology, and immune-based diseases
|
2004 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - TiGenix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tigenix Comparisons
Competitors of TiGenix
TiGenix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tenaya Therapeutics, Cellino, Arrakis Therapeutics, MyoKardia and Eiger BioPharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Therapeutics for heart and cardiovascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tigenix
Frequently Asked Questions about TiGenix
When was TiGenix founded?
TiGenix was founded in 2000 and raised its 1st funding round 6 years after it was founded.
Where is TiGenix located?
TiGenix is headquartered in Leuven, Belgium. It is registered at Leuven, Flemish Brabant, Belgium.
Is TiGenix a funded company?
TiGenix is a funded company, having raised a total of $19M across 15 funding rounds to date. The company's 1st funding round was a Post-IPO of $9.25M, raised on Jan 05, 2006.
What does TiGenix do?
TiGenix was established in 2000 in Leuven, Belgium, within the biotechnology sector. A proprietary platform of donor-derived expanded adipose-derived stem cells is employed to develop therapeutics. Key programs include Cx601 for perianal fistulas in Crohns disease and Cx611 for rheumatoid arthritis and sepsis. AlloCSC-01 involves allogeneic cardiac stem cells for acute ischaemic heart disease. ChondroCelect, approved for knee cartilage repair, is commercialized in Europe.
Who are the top competitors of TiGenix?
TiGenix's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Cellino.
How many acquisitions has TiGenix made?
TiGenix has made 2 acquisitions, including Cellerix, and Orthomimetics.
Who are TiGenix's investors?
TiGenix has 16 investors. Key investors include Takeda Pharmaceuticals, RA Capital, Kreos Capital, European Union, and Capricorn Partners.